Use access key #2 to skip to page content.
$69.08 -0.55 (-0.79%)
5/16/2008 4:00 PM

Genzyme Corp (GENZ)

CAPS Rating:
*****

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.

View All Commentary (GENZ)

Recs

0

Avatar GS751 (88.70) Submitted: 4/15/08 11:29 AM : Outperform Start Price: $72.14 GENZ Score: -11.87

A large cap play that I stole from Florida Builder. Already priced as if the R &D is gonna come through. I'll be on the betting line.

Report this Post Replies: 0 | Reply

Featured Broker Partners